| Entry |
|
|---|
| Name |
|
|---|
| Composition |
(Gal)4 (GalNAc)2 (Glc)1 (GlcNAc)2 (LFuc)2 (Cer)1
|
|---|
| Mass |
1915.8 (Cer)
|
|---|
| Structure |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00601 | Glycosphingolipid biosynthesis - lacto and neolacto series |
|
|---|
| Enzyme |
|
|---|
| Brite |
Lipids [BR:br08002]
SP Sphingolipids
SP05 Neutral glycosphingolipids
SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)
G00075 GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer
Glycan epitopes [br08111.html]
G00075
|
|---|
| Reference |
|
|---|
| Authors |
Clausen H, Levery SB, Nudelman E, Baldwin M, Hakomori S. |
|---|
| Title |
Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes. |
|---|
| Journal |
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
NODE 12
1 Cer 37 0
2 Glc 29 0
3 Gal 21 0
4 GlcNAc 12 0
5 Gal 3 0
6 GlcNAc -6 0
7 Gal -15 0
8 LFuc -23 -4
9 GalNAc -24 4
10 Gal -33 4
11 LFuc -41 0
12 GalNAc -42 8
EDGE 11
1 2:b1 1:1
2 3:b1 2:4
3 4:b1 3:3
4 5:b1 4:4
5 6:b1 5:3
6 7:b1 6:4
7 8:a1 7:2
8 9:a1 7:3
9 10:b1 9:3
10 11:a1 10:2
11 12:a1 10:3
|
|---|
